Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-25-003496

Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kalin Katherine Bach Director 2025-01-10 Grant or award +12,500 21,000 D
Derivatives
Kalin Katherine Bach Director 2025-01-10 Grant or award · Stock Option (Right to Buy) +18,500 18,500 D
Loading xslF345X05/tm253166-3_4seq1.xml…